Genmab A/S (GMAB) Stock Chart & Stock Price History $22.84 +0.59 (+2.65%) Closing price 04:00 PM EasternExtended Trading$22.40 -0.44 (-1.93%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Genmab A/S Stock Price Performance The Genmab A/S (GMAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 18.19%, with a year-to-date return of 9.44%. In the past month, the stock has increased 17.79%, reflecting recent market activity. As of the latest close, Genmab A/S traded at $22.25 with a market cap of $14.27 billion and volume of 790,871 shares. Five years ago, the stock traded at $30.22, representing a 24.42% decrease over that period. At the time, it had a market cap of $19.53 billion and a volume of 4.36 million shares. Receive GMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.72%1 Month Performance+17.79%3 Month Performance+3.91%Year-To-Date Performance+9.44%1 Year Performance-18.19%5 Year Performance-24.42% GMAB Stock Chart for Tuesday, June, 10, 2025 GMAB Chart by TradingView Genmab A/S Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/10/2025$22.25$22.84+2.65%$22.93$22.501.24 million shs$14.65 billion06/09/2025$22.20$22.25+0.23%$22.37$22.02790,871 shs$14.27 billion06/06/2025$21.81$22.20+1.79%$22.22$21.86956,446 shs$14.23 billion06/05/2025$21.78$21.81+0.14%$22.07$21.78680,200 shs$13.98 billion06/04/2025$21.35$21.78+2.01%$22.15$21.761.33 million shs$13.69 billion06/03/2025$21.77$21.35-1.93%$21.53$20.881.13 million shs$13.69 billion06/02/2025$20.93$21.77+4.01%$21.94$21.571.99 million shs$13.96 billion05/30/2025$21.32$20.93-1.83%$21.18$20.57823,934 shs$13.42 billion05/29/2025$21.19$21.32+0.61%$21.42$21.12685,051 shs$13.67 billion05/28/2025$21.28$21.19-0.42%$21.21$20.731.43 million shs$13.59 billion Get the Latest News and Ratings for GMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. 05/27/2025$20.81$21.28+2.26%$21.38$20.951.39 million shs$13.64 billion05/26/2025$20.81$20.81$20.82$20.521.25 million shs$13.34 billion05/23/2025$21.03$20.81-1.05%$20.82$20.521.25 million shs$13.34 billion05/22/2025$20.52$21.03+2.49%$21.23$20.901.97 million shs$13.48 billion05/21/2025$20.33$20.52+0.93%$20.87$20.461.54 million shs$13.16 billion05/20/2025$20.18$20.33+0.74%$20.40$20.141.03 million shs$13.04 billion05/19/2025$19.88$20.18+1.51%$20.19$19.801.06 million shs$12.94 billion05/16/2025$19.65$19.88+1.17%$19.90$19.59836,564 shs$12.75 billion05/15/2025$19.08$19.65+2.99%$19.66$19.321.04 million shs$12.60 billion05/14/2025$19.31$19.08-1.19%$19.67$19.051.71 million shs$12.23 billion05/13/2025$19.93$19.31-3.11%$19.52$18.892.20 million shs$12.38 billion05/12/2025$19.39$19.93+2.78%$19.95$19.122.60 million shs$12.78 billion05/09/2025$19.42$19.39-0.15%$19.96$19.352.19 million shs$12.43 billion Related Companies Takeda Pharmaceutical Stock Chart argenx Stock Chart BioNTech Stock Chart Beigene Stock Chart Teva Pharmaceutical Industries Stock Chart Intra-Cellular Therapies Stock Chart Summit Therapeutics Stock Chart Dr. Reddy's Laboratories Stock Chart Ascendis Pharma A/S Stock Chart Moderna Stock Chart Receive GMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GMAB) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored50-year legend: Here’s exact day stocks will crashGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GMAB Stock Free GMAB Stock Alerts